Affy Reports $85M in Preliminary Q4 Revenues | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix today reported $85 million in preliminary revenue for the fourth quarter — a 6 percent increase over $78.6 million in the fourth quarter of 2009.

The company said that its anticipated fourth-quarter 2010 revenue includes a $4.8 million milestone payment from an undisclosed diagnostic partner.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions. is eyeing an expansion into genomic risk assessments, the Verge reports.